Ping An Healthcare and Technology Company Ltd risk profile
55 Elevated one input has moved against it
Measured 1 September 2026 from 1XZ's filed statements. Recomputed nightly.
55 (Elevated), driven by Market expectation at 84, over 5 weighted categories on the SOFTWARE profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 84 | Acute | Stable | Drawdown from the 52-week high — 73.5% |
| Operating pressure | 9 | Contained | Stable | Costs outgrowing revenue — -7.9 percentage points |
| Cash conversion | 33 | Normal | Easing | Cash conversion — 1.19x |
| Leverage and coverage | 5 | Contained | Easing | Current ratio — 2.70x |
| Competitive position | 68 | Stretched | Stable | Revenue-growth gap against peers — -49.7 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 17Johnson & Johnson 37Abbvie Inc 46Roche Holding AG 32Merck & Co Inc 26Novartis AG 25Astrazeneca plc 30AMGEN Inc 33Thermo Fisher Scientific Inc 45Novo Nordisk A/S 23Abbott Laboratories 43Gilead Sciences Inc 31
Financials, valuation and price history for Ping An Healthcare and Technology Company Ltd